- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 69-83 of
276 results
1049 Exhibit: Bito LZ, ¿¿¿Comparison of the Ocular Hypotensive Efficacy of Eicosan...
Document
IPR2017-01434, No. 1049-97 Exhibit - Bito LZ, ¿¿¿Comparison of the Ocular Hypotensive Efficacy of Eicosanoids and Related Compounds,¿¿¿ Exp Eye Res, 382181¿¿¿94 1984 (P.T.A.B. Jun. 5, 201...
|
|
Cite Document
1037 Exhibit: Alan Robin, MD, ¿¿¿Two new options will make glaucoma therapy safer...
Document
IPR2017-01434, No. 1037-85 Exhibit - Alan Robin, MD, ¿¿¿Two new options will make glaucoma therapy safer,¿¿¿ Primary Care Optometry News, July 1996 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1047 Exhibit: Resul B et al, ¿¿¿Phenyl Substituted Prostaglandins Potent and Select...
Document
IPR2017-01434, No. 1047-95 Exhibit - Resul B et al, ¿¿¿Phenyl Substituted Prostaglandins Potent and Selective Antiglaucoma Agents,¿¿¿ J Med Chem, 36243¿¿¿248 1993 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1044 Exhibit: Lee P Y et al, ¿¿¿Effect of prostaglandin F2¿¿ on aqueous humor dynam...
Document
IPR2017-01434, No. 1044-92 Exhibit - Lee P Y et al, ¿¿¿Effect of prostaglandin F2¿¿ on aqueous humor dynamics of rabbit, cat, and monkey,¿¿¿ Invest Ophthalmol Vis Sci, 251087¿¿¿1093 1984 (P.T...
|
|
Cite Document
1056 Exhibit: Exhibit 1056 Aerie Pharmaceuticals, Inc Form 8 K 2018
Document
IPR2017-01434, No. 1056-104 Exhibit - Exhibit 1056 Aerie Pharmaceuticals, Inc Form 8 K 2018 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1042 Exhibit: Ikeda, Yoko et al ¿¿¿Comparison study of intraocular pressure reductio...
Document
IPR2017-01434, No. 1042-90 Exhibit - Ikeda, Yoko et al ¿¿¿Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal ten...
|
|
Cite Document
1052 Exhibit: Latanoprost DrugBank Profile, available at httpswwwdrugbankcadrug...
Document
IPR2017-01434, No. 1052-100 Exhibit - Latanoprost DrugBank Profile, available at httpswwwdrugbankcadrugsDB00654 last visited May 31, 2018 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1045 Exhibit: Patel SS et al, ¿¿¿Latanoprost A Review of its Pharmacological Proper...
Document
IPR2017-01434, No. 1045-93 Exhibit - Patel SS et al, ¿¿¿Latanoprost A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability in the Management of Primary Open Angle Glau...
|
|
Cite Document
1043 Exhibit: Fogagnolo, Paolo et al ¿¿¿A 1 Year Randomized Study of the Clinical a...
Document
IPR2017-01434, No. 1043-91 Exhibit - Fogagnolo, Paolo et al ¿¿¿A 1 Year Randomized Study of the Clinical and Confocal Effects of Tafluprost and Latanoprost in Newly Diagnosed Glaucoma Pati...
|
|
Cite Document
1032 Exhibit: Supplemental Declaration of Aron D Rose, MD
Document
IPR2017-01434, No. 1032-80 Exhibit - Supplemental Declaration of Aron D Rose, MD (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1062 Exhibit: Exhibit 1062 Appendix B to Exhibit 1032
Document
IPR2017-01434, No. 1062-110 Exhibit - Exhibit 1062 Appendix B to Exhibit 1032 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2031 Exhibit: Ex2031 Takagi 2004
Document
IPR2017-01434, No. 2031-61 Exhibit - Ex2031 Takagi 2004 (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
2042 Exhibit: Ex2042 Rescula Label
Document
IPR2017-01434, No. 2042-72 Exhibit - Ex2042 Rescula Label (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
2025 Exhibit: Ex2025 deLong Transcript
Document
IPR2017-01434, No. 2025-55 Exhibit - Ex2025 deLong Transcript (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
2030 Exhibit: Ex2030 Santen Financial Results
Document
IPR2017-01434, No. 2030-60 Exhibit - Ex2030 Santen Financial Results (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
